logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for nanotechnology industry professionals · Tuesday, April 15, 2025 · 803,476,718 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Nanotechnology News  •••  Topics  •  Countries  •  U.S. States

Nanomaterials News Monitoring

  • Published on Apr 14, 2025

    Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data

    Verve Therapeutics saw its stock surge by more than 26% when markets opened today (14 April) after the company announced early-stage clinical data for its Eli Lilly-partnered experimental gene editing therapy VERVE-102. The company reported encouraging …

    Source: Pharmaceutical Technology - Neutral
  • Published on Apr 14, 2025

    New Method for Detecting Nanoplastics in Body Fluids

    Microplastics and the much smaller nanoplastics enter the human body in various ways, for example through food or the air we breathe. A large proportion is excreted, but a certain amount remains in organs, blood and other body fluids. In the FFG bridge …

    Source: ScienceDaily - Pending
  • Published on Apr 14, 2025

    HEALTH – A digital revolution is about to transform dentistry

    Recent years have seen a growing interest in integrating advanced digital technologies into healthcare. Artificial intelligence (AI) and 3D printing are now essential tools for improving precision and personalizing treatments. But beyond technological …

    Source: Entrevue - Indeterminate
  • Published on Apr 14, 2025

    Researchers may have solved decades-old mystery behind benzodiazepine side effects

    Benzodiazepines like Valium and Xanax are often prescribed to treat anxiety, insomnia and seizures. While these drugs can be effective as a short-term treatment, researchers are trying to better understand the impact of benzodiazepines after extended use. …

    Source: EurekAlert! - Neutral
  • Published on Apr 14, 2025

    Important medical breakthrough: MRI scans can affect human tissue

    Actualizado 14/04/2025 - 09:44 CDT Normally, an MRI is used to explore the inside of the human body more thoroughly, especially to look at tissues that cannot be seen with a conventional X-ray. It is an examination that, through magnets and radio …

    Source: MARCA - Neutral
  • Published on Apr 14, 2025

    Verve shares soar after new gene-editing trial shows no safety concerns

    Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol. The Boston-based company said its treatment was well-tolerated with no serious treatment- …

    Source: The Boston Globe - Massachusetts - Neutral
  • Published on Apr 14, 2025

    Federal budget cuts and worker safety

    EXPERT Q&A One of the federal institutes focused on keeping workers safe from injury and illness on the job has lost about two-thirds of its staff due to federal budget cuts. Richard Neitzel The cuts to the National Institute for Occupational Safety …

    Source: University of Michigan News - Pending
  • Published on Apr 14, 2025

    Verve’s Base Editor ‘Numerically Beats’ Other Cholesterol-Lowering Drugs

    Verve Therapeutics’ in vivo base editing therapy, VERVE-102, lowered bad cholesterol in Phase Ib, the company announced Monday morning, leaving the company’s partner, Eli Lilly, with a decision to make. Analysts from both William Blair and BMO Capital …

    Source: BioSpace - Pending
  • Published on Apr 14, 2025

    PEGylated Niosomal Oxaliplatin Enhances Antitumor Breast Therapy

    Photo Credit: iStock - Mohammed Haneefa Nizamudeen The following is a summary of “Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer treatment,” published in the April 2025 issue of Cancer Nanotechnology by Moghaddam et …

    Source: Physician's Weekly - Neutral
  • Published on Apr 14, 2025

    VERVE-102 Safely Cuts LDL-C Levels in Early Phase 1b Results

    Initial results from the Phase 1b Heart-2 clinical trial evaluating VERVE-102 gene therapy showed promising efficacy for the treatment of patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD).1 …

    Source: HCPLive - Pending
  • Published on Apr 14, 2025

    Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose

    Verve Therapeutics Inc VERV on Monday released initial data from the Heart-2 Phase 1b trial of VERVE-102 in patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD), which requires reducing low- …

    Source: Benzinga - Neutral
  • Published on Apr 14, 2025

    STAT+: Verve gene-editing therapy lowers cholesterol without serious side effects in early study

    Verve Therapeutics said initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects, a positive step for the company after it paused development of an earlier treatment due to safety concerns. …

    Source: STAT - Massachusetts - Neutral
  • Published on Apr 14, 2025

    Pfizer discontinues its experimental GLP-1 pill

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss interesting new gene-editing data from Verve, see the NIH starting to convene advisory councils again, …

    Source: STAT - Massachusetts - Neutral
  • Published on Apr 14, 2025

    World plastic crisis: Awareness and circular economy can save the day

    The lure of plastics has been irresistible for modern civilisation. It is difficult to imagine modern life without plastics. They are ubiquitous. Whether it is our house or car or hospitals or schools, it can be seen everywhere. The global plastics market …

    Source: Firstpost - Center-right
  • Published on Apr 14, 2025

    Verve’s second swing at gene editing for heart disease shows early promise

    An experimental gene editing treatment from Verve Therapeutics appeared to safely lower cholesterol levels in a small clinical trial, giving the biotechnology company a chance to rebound from an earlier setback. Verve has been working on a one-time …

    Source: BioPharma Dive - Pending
  • Published on Apr 14, 2025

    Marama Labs’s CloudSpec could set ‘new gold standard’, CEO says

    The start-up, which has created a novel spectrophotometer, plans on raising a fresh Series A round this year, CEO Brendan Darby said. Marama Labs, a medtech dually based in New Zealand and Ireland, recently announced the launch of its CloudSpec instrument …

    Source: Silicon Republic - Neutral
  • Published on Apr 14, 2025

    Vegetable compound's 'strong impact' on brain health could hold key to treating dementia say scientists

    A natural compound found in common fruits and vegetables may help treat neurodegenerative diseases, according to new research. The findings suggest the compound kaempferol shows promise as a potential treatment for conditions like ALS and dementia. " …

    Source: GB News - Right-wing
  • Published on Apr 14, 2025

    MRI scans linked to harmful material formation in the body

    Gadolinium-based contrast agents (GBCAs) are commonly used in MRIs to make images clearer. The gadolinium in these agents is usually tightly bound to other molecules and leaves the body without harming most people. However, studies have found that tiny …

    Source: Tech Explorist - Neutral
  • Published on Apr 14, 2025

    Integrity at all times

    Across industries, scanning electron microscopy (SEM) is unlocking breakthroughs by providing a deeper understanding of the structural and chemical properties of materials. For instance, in battery research, SEM characterisation of lithium-ion (Li-ion) …

    Source: Laboratory News - Neutral

06 days 12:18:30

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more nanotechnology news or search news using your own keywords. There are 803,476,718 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Nanotechnology News by Country >
Nanotechnology News by U.S. State >
Nanotechnology News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory >

Technology Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Technology Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Nanotechnology News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement